Navigation path

Please select a Step first


Results: 11 - 20 of 71
Download

Bovine Oocyte Maturation Assay

Test Method Number: TM2010-05 (EU)
Short Name of TM: IVM
Responsible Organisation: EURL ECVAM - European Union
General Comments:

On hold-pending further information

Stage of Submission: Assessment of Pre-submission
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Embryonic Rat Dorsal Root Ganglia Organotypic Culture

Test Method Number: TM2010-06 (EU)
Short Name of TM: DRG
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Not prioritised for validation by ECVAM since it has not fulfilled ECVAM requirements.

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Transcriptional activation assay for detection of androgenic activity of chemicals

Test Method Number: TM2010-07 (EU)
Short Name of TM: AR-CALUX
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Under validation

Stage of Submission: Assessment Finalised
Stage of Validation: Ongoing
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Dequenching after photobleaching cytotoxicity test

Test Method Number: TM2011-01 (EU)
Short Name of TM: DAP assay
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Submission closed because replaced by another version of the test method in subsequent submission (TM2014-05)

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Genomic Embryonic Stem cell Test method

Test Method Number: TM2012-04 (EU)
Short Name of TM: gEST
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Not considered for follow-up

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Thyroid receptor microarray assay for real-time Nuclear Receptor-coregulator interaction

Test Method Number: TM2017-02 (EU)
Short Name of TM: TR MARCoNI
Responsible Organisation: EURL ECVAM - European Union
General Comments:
Stage of Submission: Receipt of Pre-submission
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Fish cell line acute toxicity test

Test Method Number: TM2014-01 (EU)
Short Name of TM: RTgill-W1
Responsible Organisation: EURL ECVAM - European Union
Stage of Submission: Assessment of Pre-submission
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

H2AX ICW method, gH2AX In cell western

Test Method Number: TM2014-02 (EU)
Short Name of TM: H2AX ICW
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Not prioritised for validation by ECVAM since it has not fulfilled ECVAM criteria.

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

Transepithelial permeability assessment using an in vitro cell model of the human airway epithelium

Test Method Number: TM2014-03 (EU)
Short Name of TM: MucilAir
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Considered to be followed up in the wider context of ADME methods

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards

devTOX qp (Stemina) devTOX quick Predict

Test Method Number: TM2014-04 (EU)
Short Name of TM: devTOXqP
Responsible Organisation: EURL ECVAM - European Union
General Comments:

Not considered for validation studies based on PARERE consultation opinion.

Stage of Submission: Not considered for validation
  • 1
    Submission
  • 2
    Validation
  • 3
    Peer-review
  • 4
    Recommendation
  • 5
    Regulatory acceptance/Standards